Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Aldeyra Therapeu (NQ: ALDX ) 5.370 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Aldeyra Therapeu < Previous 1 2 3 4 5 Next > Aldeyra's New Eye Drug Shows Positive Results In FDA-Approved Study, Stock Jumps Over 30% August 08, 2024 Aldeyra Therapeutics announces successful results from its Phase 3 clinical trial of reproxalap. The results support a potential 2024 NDA resubmission. Via Benzinga ALDX Stock Earnings: Aldeyra Therapeutics Meets EPS for Q1 2024 May 03, 2024 ALDX stock results show that Aldeyra Therapeutics met analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Aldeyra Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying April 04, 2024 The Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Tuesday's After-Market Session March 05, 2024 Via Benzinga Positive News For Skin Health: Aldeyra Therapeutics' ADX-629 Achieves Key Milestones in Atopic Dermatitis Study December 19, 2023 Aldeyra Therapeutics Inc (NASDAQ: ALDX) released topline results from a Phase 2 clinical trial of ADX-629, an investigational RASP modulator, in Via Benzinga Expert Ratings for Aldeyra Therapeutics August 09, 2023 Via Benzinga Analyst Ratings for Aldeyra Therapeutics June 22, 2023 Via Benzinga 3 Stocks at the Forefront of Personalized Medicine Trend December 05, 2023 Unveiling the impact of personalized medicine stocks, transforming patient care, and propelling market growth seamlessly Via InvestorPlace FDA Rejects Aldeyra Therapeutics' Dry Eye Disease Candidate, Asks For Additional Study November 28, 2023 The FDA issued a complete response letter to Aldeyra Therapeutics Inc's (NASDAQ: ALDX) New Drug Application (NDA) of reproxalap, an investigational drug Via Benzinga Exposures Product Safety Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session November 01, 2023 Gainers Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session November 01, 2023 Via Benzinga What's Going On With Aldeyra Therapeutics Stock? November 01, 2023 Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) shares are trading higher Wednesday after the company announced that it entered into an exclusive opti Via Benzinga Why Are Stocks Up Today? November 01, 2023 Stocks are up today as investors prepare for the most recent information from the Federal Reserve concerning interest rates. Via InvestorPlace Topics Economy Exposures Interest Rates Why Is Aldeyra Therapeutics (ALDX) Stock Up 40% Today? November 01, 2023 Aldeyra Therapeutics stock is rising with heavy trading of ALDX shares after signing an exclusive option agreement with AbbVie. Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's Pre-Market Session November 01, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023 October 17, 2023 Via Benzinga Crude Oil Moves Lower; Consolidated Communications Shares Jump October 16, 2023 U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining over 1% on Monday. The Dow traded up 0.93% to 33,983.22 while the NASDAQ rose 1.31% to 13,582.67. The S&P 500 also rose,... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 12 Health Care Stocks Moving In Monday's Intraday Session October 16, 2023 Via Benzinga Nasdaq Gains 1%; Charles Schwab Earnings Top Views October 16, 2023 U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Monday. The Dow traded up 1.02% to 34,012.79 while the NASDAQ rose 1% to 13,541.79. The S&P... Via Benzinga Topics Stocks Exposures US Equities Dow Surges Over 200 Points; Empire State Manufacturing Index Falls In October October 16, 2023 U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 200 points on Monday. The Dow traded up 0.72% to 33,913.22 while the NASDAQ rose 0.46% to 13,468.82. The S&P 500 also... Via Benzinga Topics Stocks Exposures US Equities Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session October 16, 2023 Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday. Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session October 16, 2023 Via Benzinga Why Aldeyra Therapeutics (ALDX) Stock Is Getting Obliterated October 16, 2023 Aldeyra Therapeutics Inc (NASDAQ: ALDX) shares are trading lower by 62% to $2.07 during Monday's pre-market session. The company on Monday morning received feedback from the U.S. Via Benzinga Manchester United, Trip.com Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session September 05, 2023 U.S. stock futures traded higher this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga Aldeyra Therapeutics' Chronic Cough Potential Shows Significant Reduction In Cough Frequency Versus Placebo June 27, 2023 Aldeyra Therapeutics Inc (NASDAQ: ALDX) announced top-line results from the Phase 2 clinical trial of ADX‑629, an investigational new drug administered orally to Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session June 21, 2023 Via Benzinga Why Are Aldeyra Therapeutics Shares Plummeting Today June 21, 2023 Aldeyra Therapeutics Inc (NASDAQ: ALDX) has received a Complete Response Letter from the FDA for the 505(b)(2) New Drug Application (NDA) of ADX-2191 (methotrexate for injection) for Via Benzinga Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 15, 2023 Gainers SCWorx Corp. (NASDAQ: WORX) shares jumped 281% to $0.8396. Via Benzinga Why Aldeyra Therapeutics Stock Is Trading Higher Today June 15, 2023 Aldeyra Therapeutics Inc (NASDAQ: ALDX) reported topline results from the Phase 3 INVIGORATE-2 trial of 0.25% reproxalap ophthalmic solution, an investigational new drug, in Via Benzinga Domino's Pizza, Patterson-UTI Energy, JinkoSolar And Other Big Stocks Moving Higher On Thursday June 15, 2023 U.S. stocks traded higher, with the Dow Jones gaining around 180 points on Thursday. Here are some big stocks recording gains in today’s session. Nikola Corporation (NASDAQ: NKLA) jumped 19.9% to... Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.